Recursion Pharmaceuticals Inc (RXRX) USD0.00001 A

Sell:$4.46Buy:$4.47Price decreased$0.12 (2.50%)

NASDAQ:Price increased0.17%
Market closed |
Prices delayed by at least 15 minutes
Sell:$4.46
Buy:$4.47
Change:Price decreased$0.12 (2.50%)
Market closed |
Prices delayed by at least 15 minutes
Sell:$4.46
Buy:$4.47
Change:Price decreased$0.12 (2.50%)
Market closed |
Prices delayed by at least 15 minutes

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

Recent deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
20 January 2026
Christopher (Chris) GibsonCEO
Sell
Regular sell transaction (market)
40,000$4.47$178,800.00913,839
6 January 2026
Blake Charles BorgesonOther Level A
Sell
Regular sell transaction (market)
220,000$4.36$959,200.006,649,863
5 January 2026
Christopher (Chris) GibsonCEO
Sell
Regular sell transaction (market)
40,000$4.25$170,000.00933,839
29 December 2025
Ben R TaylorCFO
Sell
Regular sell transaction (market)
21,383$4.18$89,380.94761,550
22 December 2025
Najat KhanChief Level Officer
Sell
Regular sell transaction (market)
124,403$4.41$548,592.35611,135
19 December 2025
Christopher (Chris) GibsonCEO
Sell
Regular sell transaction (market)
40,000$4.50$180,000.00913,839
15 December 2025
Ben R TaylorCFO
Sell
Tax related
7,057$4.33$30,556.81782,933
4 December 2025
Christopher (Chris) GibsonCEO
Sell
Regular sell transaction (market)
40,000$4.63$185,200.00933,839
2 December 2025
Blake Charles BorgesonOther Level A
Sell
Regular sell transaction (market)
220,000$4.37$961,400.006,869,863
25 November 2025
Ben R TaylorCFO
Sell
Tax related
2,271$4.03$9,152.13789,990

5 most significant deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
11 August 2025
Christopher (Chris) GibsonCEO
Sell
Regular sell transaction (market)
500,300$5.28$2,641,584.001,004,619
2 December 2025
Blake Charles BorgesonOther Level A
Sell
Regular sell transaction (market)
220,000$4.37$961,400.006,869,863
6 January 2026
Blake Charles BorgesonOther Level A
Sell
Regular sell transaction (market)
220,000$4.36$959,200.006,649,863
27 March 2025
Christopher (Chris) GibsonCEO
Sell
Regular sell transaction (market)
138,574$6.04$836,986.961,117,450
10 October 2025
Christopher (Chris) GibsonCEO
Sell
Regular sell transaction (market)
100,000$6.04$604,000.00974,229

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.